Literature DB >> 27896405

The Totally Implantable Venous Access Device with Occurrence of Pneumothorax Still Remains an Issue.

Isidoro Di Carlo1, Adriana Toro2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 27896405     DOI: 10.1007/s00268-016-3850-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  3 in total

Review 1.  Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?

Authors:  Roberto Biffi; Adriana Toro; Simonetta Pozzi; Isidoro Di Carlo
Journal:  Support Care Cancer       Date:  2014-06       Impact factor: 3.603

2.  External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement.

Authors:  Isidoro Di Carlo; Francesco Barbagallo; Adriana Toro; Maria Sofia; Rosario Lombardo; Stefano Cordio
Journal:  Ann Surg Oncol       Date:  2005-05-05       Impact factor: 5.344

3.  Ultrasound-Guided Placement of Central Venous Port Systems via the Right Internal Jugular Vein: Are Chest X-Ray and/or Fluoroscopy Needed to Confirm the Correct Placement of the Device?

Authors:  Michelangelo Miccini; Diletta Cassini; Matteo Gregori; Sergio Gazzanelli; Simone Cassibba; Daniele Biacchi
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

  3 in total
  2 in total

1.  Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)?

Authors:  Adriana Toro; Elena Schembari; Edoardo Mattone; Isidoro Di Carlo
Journal:  World J Surg       Date:  2020-03       Impact factor: 3.352

Review 2.  Forty years after the first totally implantable venous access device (TIVAD) implant: the pure surgical cut-down technique only avoids immediate complications that can be fatal.

Authors:  Adriana Toro; Elena Schembari; Emanuele Gaspare Fontana; Salomone Di Saverio; Isidoro Di Carlo
Journal:  Langenbecks Arch Surg       Date:  2021-06-09       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.